Sunvozertinib overcoming resistance to afatinib and osimertinib in lung adenocarcinoma harboring an EGFR exon 18 DelE709_T710insD mutation
2024 · Journal of Translational Medicine · 2 citations
https://doi.org/10.1186/s12967-024-05522-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
19
Citations
2
h-index
1
i10-index
Kaibo Ding is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Fractional Differential Equations Solutions & Nonlinear Differential Equations Analysis. The author has an h-index of 2, co-authored 9 publications.
Click to start Chat